Wilson W A
Department of Medicine, Louisiana State University Medical Center, New Orleans, Louisiana, USA.
Rheum Dis Clin North Am. 2001 Aug;27(3):499-505, v. doi: 10.1016/s0889-857x(05)70216-7.
The major purpose of the 1999 international consensus criteria for definite antiphospholipid syndrome (APS) is to facilitate the selection of uniform groups of patients for clinical and experimental studies. An early evaluation suggests that the criteria fulfill this purpose when tested in patients with systemic lupus erythematosus or lupus-like diseases. The criteria will likely need modification as investigators appraise and reach consensus about new information on APS. The international APS symposium has had an important role in this process and provides a mechanism for facilitating future advances in this subject.
1999年明确抗磷脂综合征(APS)国际共识标准的主要目的是便于为临床和实验研究选择统一的患者群体。早期评估表明,该标准在系统性红斑狼疮或狼疮样疾病患者中进行测试时可实现这一目的。随着研究人员对APS新信息进行评估并达成共识,该标准可能需要修订。国际APS研讨会在这一过程中发挥了重要作用,并为推动该领域未来的进展提供了一种机制。